Functional annotation of complex genomes requires the development of novel experimental platforms with increased capacity. Here, we describe a high-throughput system designed to identify cDNAs whose overexpression induces morphologically distinct cell death modalities. The methodology incorporates two robotized steps, and relies on coexpression of library clones with GFP to reveal the morphological features presented by the dying cells. By using this system we screened 135 000 cDNA clones and obtained 90 independent molecules. Interestingly, three death categories were identified, namely; apoptotic, vacuolated and autophagic. Among the pro-apoptotic clones, we found four members of the mitochondrial carrier family: the phosphate and adenine nucleotide (type 3) transporters, and the mitochondrial carrier homologs (MTCHs) 1 and 2. Expression of these molecules induced cytochrome c release and caspase-9-dependent death. One of them, the phosphate carrier, was able to interact with members of the permeability transition pore complex ANT1 and VDAC1, and its binding to ANT1 was stabilized in the presence of apoptotic activators. Depletion of this carrier by siRNA delayed cytochrome c mobilization and apoptosis. These results attribute a previously undescribed apoptotic function to the phosphate carrier and, more generally, suggest that a common property of various mitochondrial transporters was exploited during evolution to regulate apoptosis.
Introduction
The complete genomes of a number of organisms have been recently sequenced and functional annotation of all genes uncovered constitutes one of the challenges of the post-genomic era. To address this issue, a substantial effort has been made to design experimental methodologies with increased analytical capacity (Grimm, 2004; Kiss-Toth et al., 2004) . One of them is a variation of expression cloning where cDNA collections are expressed in cultured cells and tested for their ability to regulate simple readout reporters (Grimm, 2004; Kiss-Toth et al., 2004; Ting et al., 2005) . The recent advent of high-throughput robotic systems facilitates massification of these approaches, turning them into powerful tools for functional gene discovery. Most of these methods rely on a property that signal transduction mediators often share: the ability to induce downstream signaling upon overexpression in susceptible cells. For example, transfection of molecules involved in nuclear factor-kB (NF-kB) activation stimulates the signaling pathway, a feature that has been exploited in screenings aimed at finding NF-kB inducers (Matsuda et al., 2003) . A comparable rationale has supported the design of cloning systems to identify activators of the MAPK pathway (Chanda et al., 2003; Matsuda et al., 2003) or modifiers of amyloid protein shedding (Schobel et al., 2006) . Similarly, expression of apoptotic mediators activates the death program and, based on this, massive screenings to find pro-apoptotic clones have been developed (Albayrak and Grimm, 2003) .
Although apoptosis is the paradigm of programmed cell death, other forms of cell demise are also genetically regulated (Broker et al., 2005) . Apart from relying on alternative molecular mechanisms, these atypical death modes are accompanied by changes in cellular morphology that are markedly distinct from the blebbing and cell shrinkage that characterize apoptosis (Broker et al., 2005) . For example, autophagic (Type II) cell death causes cells to detach from the substrate and adopt a ballooned appearance (Shimizu et al., 2004) . In turn, paraptosis, or Type III death, involves extensive cytoplasmic vacuolization (Van Cruchten and Van Den Broeck, 2002; Broker et al., 2005) . Several examples suggest that overexpression of molecules involved in atypical death also activates the execution machinery. Death-associated protein kinase plays a role in autophagic death, and its expression induces this type of cell demise (Inbal et al., 2002) . BCL2/adenovirus 19 kdinteracting protein (NIP) mediates arsenic trioxideinduced autophagy and activates autophagic death upon transfection (Kanzawa et al., 2005) . Similarly, paraptotic death is induced by expression of insulin-like growth factor-I receptor (Sperandio et al., 2000) .
Given these premises, we reasoned that we could identify signaling mediators involved in a variety of death programs by screening cDNA expression libraries for clones capable of inducing morphologically distinct cell death modalities. To design this cloning system, we relied on robotic devices able to handle an extensive collection of clones. Co-transfection of library DNA with a plasmid expressing green fluorescent protein (GFP), facilitated identification of the morphological features associated with cell death. The library was divided in pools of an optimized size to increase the capacity of the system.
We describe here the completion of this cloning scheme over 135 000 clones of a human cDNA library. The screening resulted in the identification of 90 clones able to induce three different morphological classes of cell death, only one of them being clearly apoptotic. We also show that one of the confirmed pro-apoptotic molecules, the mitochondrial phosphate carrier (PiC), has a previously undescribed role in the release of cytochrome c from mitochondria during apoptosis.
Results
To develop a screening system based on the analysis of pooled library clones, we first established the optimal pool size. Plasmids expressing known pro-apoptotic molecules were progressively diluted in empty plasmid DNA, mixed with a vector expressing GFP and transfected into 293T cells. The appearance of apoptotic signs was detectable even at dilutions as low as 1/100, owing to the presence of GFP in transfected cells (not shown). On the basis of these results, we chose a pool size of 96 clones for the initial screening step of a highthroughput protocol designed to identify molecules whose expression induces cell death (Figure 1) .
By applying this scheme to 135 000 clones of a human expression library, we isolated 229 cDNAs able to provoke morphological alterations in transfected cells that were compatible with cellular demise. To confirm the loss of viability, we verified the induction of an increased permeability to propidium iodide (PI). A total of 181 clones caused positive PI staining (not shown), indicating that 48 molecules triggered morphological changes that did not result in actual death. Most of these were 'weak inducers' of cell death, usually identified in primary pools also containing a 'strong inducer'. Sequencing of the killer clones reduced the collection to 90 non-redundant members (Table 1) . Several cDNAs were established apoptotic mediators, such as BAX, caspase-4, the voltage-dependent anion channel-1 (VDAC1) or CD95 (Table 1) , thus validating the capacity of the system to identify meaningful regulators.
Although most clones induced the canonical apoptotic morphology, a number of them provoked atypical alterations suggestive of alternative death modalities. Thus 12 molecules caused cytoplasmic vacuolization, while 14 induced collapse of the cellular content inside ballooned, floating structures (Table 1) . Representative examples of these phenotypes are shown in Figure 2a . Figure 1 Expression-cloning scheme. cDNA library clones were arrayed into 384-well plates. Ninety-six colony pools were subsequently generated from each of the four indicated plate sectors. Pool plasmid DNA was then cotransfected with a plasmid expressing GFP into 293T cells, and death was detected 36 h later. Isolation of positive clones was carried out by subpooling all rows and columns of each positive pool and cotransfecting the resulting 24-plasmid preparations with GFP. Positive clones were located at the intersection between positive rows and columns.
Role of the phosphate carrier in cytochrome c release S Alcalá et al Two vacuolization subcategories were further distinguishable (Table 1) . A total of eight clones induced irregular and perinuclear vacuolae (for instance, a homolog of the anterior pharynx defective protein-1, APH1; Figure 2a ), whereas four molecules provoked round and evenly distributed ones (for example, the microtubule affinity-regulated kinase-2 (MARK2); Figure 2a ). Cytoplasmic vacuolization is frequently observed during nonapoptotic death, and it is sometimes caused by dilation of the endoplasmic reticulum (Van Cruchten and Van Den Broeck, 2002; Broker et al., 2005) . Co-transfection with a version of RFP targeted to reticular cisternae (erRFP; Klee and Pimentel-Muin˜os, 2005) showed that the irregular vacuolae induced by APH1 appeared filled with this marker, thus revealing their reticular origin ( Figure 2b ). On the contrary, the round vacuolae provoked by MARK2 excluded erRFP (Figure 2b ), indicating that both vacuolization processes are, in fact, different. Detachment from the substrate and ballooned appearance have been associated with autophagic cell death (Shimizu et al., 2004) . To evaluate if MYM6 (an unknown Zn-finger-containing protein representative of this morphological type) was able to induce autophagy, we used human LC3A as a reporter system. LC3 translocates to autophagosomes upon their formation while undergoing a concomitant lipid addition that reduces its apparent molecular weight (Mizushima, 2004) . Overexpression of MYM6 activated both the redistribution of LC3A to vesicular structures ( Figure 2c , top panel) and a decrease in its molecular weight ( Figure 2c , middle panel), in both cases to an extent comparable to NIP, a known pro-autophagic protein (Kanzawa et al., 2005) . Electron microscopy studies revealed the proliferation of double-membrane vesicles, an additional feature of autophagy ( Figure 2c , bottom panel). Therefore, MYM6 induces autophagy, suggesting that the ballooned morphology caused by its expression is the consequence of autophagic death.
Different modes of cell death are further distinguishable by their variable reliance on the caspase apoptotic machinery (Broker et al., 2005) . As expected, death induced by RIP3 was blocked by the pan-caspase inhibitor zVAD.fmk (Figure 2d ), whereas both molecules causing vacuolization were partially resistant ( Figure 2d ) and the autophagic clone showed complete insensitivity ( Figure 2d ). Therefore, although we have not systematically analysed all clones to evaluate how general is the correlation between the different morphologies and the other parameters evaluated, all these data suggest that we have cloned molecules capable of inducing different types of cell death.
Four of the identified clones are known members of the mitochondrial carrier family (Table 1) , a group of proteins involved in metabolite transportation across the inner mitochondrial membrane (Palmieri, 2004) . Role of the phosphate carrier in cytochrome c release S Alcalá et al Two of them, the PiC and the adenine nucleotide transporter 3 (ANT3), show the classical structure with three homology domains (Palmieri, 2004) , while the other two, MTCH1 and 2, have only one family domain (Yerushalmi et al., 2002) . ANT3 is known to be proapoptotic (Zamora et al., 2004) . MTCH1 is a mitochondrial pro-apoptotic molecule cloned as a presenilin-1 interactor (Xu et al., 2002) . MTCH2 was identified as an mRNA induced by the hepatocyte growth factor (Yerushalmi et al., 2002) , and is involved in a protein complex with the apoptotic effectors Bid and Bax (Grinberg et al., 2005) . All these carriers were inducers of the classical apoptotic morphology, although MTCH2 provoked some cytoplasmic vacuolization that preceded the appearance of apoptotic signs (Table 1) .
ANT, the prototypical member of the carrier family (Palmieri, 2004) , is believed to participate in the permeability transition pore complex (PTPC), a mitochondrial assembly also including the outer membrane protein VDAC and matrix cyclophilin D (Zamzami and Kroemer, 2001; Crompton et al., 2002) . This pore mediates apoptosis by causing a permeability increase of the inner mitochondrial membrane that results in matrix swelling, outer membrane rupture and release of cytochrome c (Brenner and Grimm, 2006) . Consistent with the apoptotic function of the PTPC, overexpression of ANT (isoform 1) induces apoptosis (Bauer et al., 1999) . Thus, there are both structural and functional characteristics shared by the cloned carriers and ANT, raising the possibility of a similar function in apoptosis. To test this notion, we first established the ability of the carriers to activate canonical apoptosis. Expression of all molecules in 293T cells induced both the proteolytic processing of the caspase-3 substrate poly-(ADP-ribose) polymerase (PARP; Figure 3a) and a low molecular weight DNA ladder (Figure 3b) , two apoptotic features. Their capacity to activate PARP cleavage was higher than that of ANT2, an inactive member of the family (Figure 3a ; Bauer et al., 1999) . This pro-death activity was reproduced in other cell lines (Figure 3c) . Some of these results confirm previous studies ascribing an apoptotic potential to MTCH1 and ANT3 (Xu et al., 2002; Zamora et al., 2004) .
To investigate the signaling pathway involved, we co-transfected the molecules with known inhibitors of apoptosis. Both a dominant-negative version of caspase-9 and the caspase inhibitor p35 blocked PARP processing induced by carrier expression (Figure 4a ). This result points to the implication of caspase-9, the main protease activated by cytochrome c release (Green and Reed, 1998) . Consistent with this, transfection of all clones provoked the liberation of cytochrome c from mitochondrial stores (Figure 4b ). Antiapoptotic members of the BCL-2 family are known to protect cells from apoptosis induced by a variety of stimuli, including expression of the PTPC component ANT1 (Schubert and Grimm, 2004) . Coexpression of the carriers with BCL-XL, a protective BCL-2 homolog (Green and Reed, 1998) , inhibited PARP processing, with the most pronounced effect in the cases of PiC and MTCH2 (Figure 4c ). These results show that the cloned mitochondrial carriers induce apoptosis in a manner reminiscent of PTPC components, suggesting a possible participation in the pore.
To explore this idea, we turned to coimmunoprecipitation experiments. Large amounts of transfected PiC and ANT3 could be detected in HA-ANT1 immunoprecipitates (Figure 5a ), whereas MTCH2 and MTCH1 were undetectable (Figure 5a) . Similarly, HA-VDAC1 immunoprecipitates contained PiC and ANT3, although the highest signal was present in the MTCH2 lane (Figure 5b ). Again, MTCH1 was barely detectable (Figure 5b) . Therefore, both PiC and ANT3 can associate with ANT1 and VDAC1, whereas MTCH2 shows the ability to bind VDAC1. Complexes were strikingly stable, as they were resistant to washes in high salt conditions. 
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These data prompted us to consider a regulatory role in apoptotic pathways of the carriers involved in these contacts. Since an apoptotic function for ANT3 had already been investigated (Zamora et al., 2004) , we focused on PiC and MTCH2. We first tested if their interaction with PTPC components increases in response to apoptotic inducers. Preliminary experiments indicated that staurosporine (STS), a well-known apoptotic stimulus, induced marginal cytochrome c release in 293T cells, while HeLa cells responded strongly (not shown). In light of this, we chose the latter for this assay. Exposure of HeLa cells to STS provoked an early increase in the amount of transfected PiC coprecipitating with either transfected ANT1 (Figure 6a ) or endogenous ANT (Figure 6b) . No increased binding of PiC or MTCH2 to VDAC1 was seen in similar conditions (not shown).
These results suggest that PiC incorporates to the PTPC during the onset of STS-induced apoptosis. To explore a possible function in cytochrome c exit, we performed knock-down assays using small interfering RNAs (siRNAs). Silencing of PiC resulted in a decreased fraction of cells showing cytochrome c mobilization after STS treatment (Figure 7a ), an effect reproduced by different PiC siRNA species (Figure 7b ). Reduced levels of the established mediator ANT1 rendered a similar protection (Figure 7a ), while MTCH2 diminution provided almost no resistance (Figure 7a ). PiC depletion had no gross impact on mitochondrial function since mitochondria kept their ability to incorporate mitotracker, a polaritation-sensitive dye (Figure 7c ). Reduced PiC expression also inhibited other STS-induced apoptotic parameters like chromatin condensation (Figure 7d ) or caspase activation (Figure 7e ).
Discussion
Results shown here indicate that the pro-apoptotic activity of overexpressed PiC reflects a physiological function in apoptotic pathways. Evidence presented proves that this carrier has an active role in regulating the liberation of cytochrome c from mitochondria, perhaps through a direct intervention in the PTPC.
Although there is an ongoing controversy regarding the universality of mitochondrial permeability transition (mPT) as the main mechanism for cytochrome c release (Garrido et al., 2006) , abundant pharmacological evidence links both phenomena in a number of systems (Zamzami and Kroemer, 2001) . It is believed that a pore minimally built by ANT, VDAC and cyclophilin D mediates mPT (Zamzami and Kroemer, 2001; Crompton et al., 2002) . However, some contradicting results point Role of the phosphate carrier in cytochrome c release S Alcalá et al to a more flexible structure (Zoratti et al., 2005) . For example, data relating mPT and apoptosis are strongly based on drugs targeting ANT, suggesting a central role for this carrier (Zamzami and Kroemer, 2001) . On the contrary, recent studies indicate that a functional PTPC can assemble in the genetic absence of ANT (Kokoszka et al., 2004) , raising the notion that alternative, noncanonical pores may exist (Halestrap, 2004; Zoratti et al., 2005) .
Additional data are also compatible with the existence of different PTPCs. For example, the pore shows multiple conductance states, suggesting the involvement of several functional units (Zoratti et al., 2005; Brenner and Grimm, 2006) . In addition, ANT1 can be purified as part of multiple mitochondrial subcomplexes whose composition and oligomerization state depend on the metabolic context (Ko et al., 2003; Faustin et al., 2004; Brenner and Grimm, 2006) . Also, the pattern of ANT-interacting proteins changes over time during chemotherapy-induced apoptosis (Verrier et al., 2004) . Therefore, ANT appears to engage in flexible contact networks that are modulated by both the metabolic status and apoptotic pressure, making it difficult to identify a pore complex with a unique molecular composition (Zoratti et al., 2005; Brenner and Grimm, 2006) .
Coincidentally, PiC seems to participate in similar interaction networks doubly involved in metabolic regulation and apoptosis. Thus, this carrier establishes weak contacts with ANT and ATP synthase to form the 'ATP synthasome', a complex that presumably facilitates substrate usage during the metabolic generation of ATP (Ko et al., 2003) . Results shown here now indicate that the interaction between PiC and ANT1 is stabilized under apoptotic pressure, suggesting an induced transition to a 'death mode' that might reflect a participation in the PTPC. Further evidence is consistent with this involvement. For example, the pore shows Pi dependency in some systems (Zoratti et al., 2005) , pointing to the presence of a Pi-sensitive subunit. In addition, PiC (like other carriers) can form channels in planar bilayers (Zoratti et al., 2005) , and our data also reveal both the ability of PiC to interact with VDAC1 and its role in cytochrome c release. Although obviously more studies are needed to formally demonstrate that PiC can contribute to the PTPC and mPT, all these data argue that this is a plausible notion. In fact, a possible role for PiC in a non-canonical pore that explains how mPT occurs in the absence of ANT has already been proposed (Halestrap, 2004; Zoratti et al., 2005) . Also supporting a function in apoptosis, PiC has recently been described as a target of the anti-apoptotic protein vMIA (Poncet et al., 2006) .
ANT-devoid mitochondria require higher calcium levels to trigger permeability changes (Kokoszka et al., 2004) . Thus, although not essential, ANT likely regulates mPT and cytochrome c exit, a view now reinforced by our siRNA results (see Figure 7a) . Data in the same figure also ascribe a partial role to PiC in cytochrome c release. In fact, drugs inhibiting particular pore components often yield incomplete cell death protection (Zoratti et al., 2005; Brenner and Grimm, 2006) . These recurrent partial contributions might be explained by the involvement of different pore entities simultaneously cooperating to induce mPT. This view could also help understand why we have identified other mitochondrial carriers in our screening. Thus, both the pro-apoptotic activity of ANT3, MTCH1 and MTCH2 as well as their variable ability to interact with PTPC components might simply reflect a potential to build a Role of the phosphate carrier in cytochrome c release S Alcalá et al variety of functional pores. Again, more studies are needed to sustain this idea.
In summary, through the use of our cloning system, we have expanded to other members of the carrier family a function believed to be restricted to specific molecules. These results suggest that a common property of a number of mitochondrial transporters was exploited during evolution to regulate apoptosis, and further support the notion that mitochondria are central to the control of apoptotic death. Finally, our screening protocol has produced a wide collection of molecules capable of inducing both apoptotic and atypical death processes. We anticipate that a close scrutiny of these clones will help us gather more insight into the molecular mechanisms that govern both death modalities.
Materials and methods
Cell lines and reagents 293T, HeLa and HCT116 cells (ATCC) were cultured at 371C and a humidified 5% CO 2 atmosphere, in DMEM plus 10% FBS and 100 U/ml of penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA). zVAD.fmk was from Becton Dickinson (San Jose, CA, USA). STS and PI were from Sigma (St Louis, MO, USA).
Screening methods
Bacterial clones of a cDNA expression library from activated human T cells (Edge Biosystems, Gaithersburg, MD, USA) were picked and pooled using the QpixII robot (Genetix, Hampshire, UK). Plasmid DNA was obtained using a Qiagen Biorobot-3000. Transfections were performed with the calcium phosphate precipitation method. Transfected cultures were scored in vivo using an inverted fluorescence microscope.
DNA constructs, transfections and retroviral transductions cDNAs were N-terminally tagged by PCR, with the exception of PiC (C terminus). Truncated MTCH1 was completed by amplification of the missing 5 0 part from a cDNA library. VDAC1, NIP and ANT2 cDNAs were screening clones. ANT2 was a weak inducer that did not provoke PI intake (see results). Human LC3A (NM_032514) and ANT1 (NM_001151) cDNAs were amplified from a cDNA library. All cDNAs were sequenced and cloned into the pEAK expression plasmid (Edge Biosystems). Mitochondrial GFP (mGFP) was built by fusing the mitochondrial localization sequence of the ornitine transcarbamilase (a gift from Dr Ute Moll) at the N terminus of GFP. Other constructs were described elsewhere (Pimentel-Muin˜os and Seed, 1999; Klee and Pimentel-Muin˜os, 2005) .
293T cells were transfected with the calcium phosphate precipitation method; HeLa and HCT116 with Fugene (Roche, Mannheim, Germany) and JetPEI (Polyplus, Illkirch, France) respectively. Retroviral transductions were carried out using the vector P12-MMP (a gift from Dr F Randow), a derivative of the pMMP vector (Dr R Mulligan). Viruscontaining supernatants were generated by cotransfecting 293T cells with the P12-MMP construct and plasmids expressing the gag-pol (pMD.gag-pol) and envelope (VSV-G; pMD-G) helper activities. Infections were carried out in the presence of polybrene (8 mg/ml, Sigma).
Western blotting
Cell lysis and immunoblotting were performed as described (Klee and Pimentel-Muin˜os, 2005) . Membranes were probed with antibodies against PARP (Becton Dickinson), caspase-9 (Cell Signaling, Danvers, MA, USA), MTCH2 (Ab3, a gift from Dr A Gross), actin (Sigma), ANT (Santa Cruz, Santa Cruz, CA, USA), AU1 or HA (Covance, Princeton, NJ, USA).
Death assays
The formation of an apoptotic DNA ladder was assayed as described (Pimentel-Muin˜os and Seed, 1999) . For the evaluation of membrane integrity, cultures were treated with PI (1 mg/ml) and scored in vivo for nuclear staining using an inverted fluorescence microscope. Chromatin condensation was revealed by DAPI staining (1 mg/ml). To measure mitochondrial polarization, cells were stained with Mitotracker (100 nM; Molecular Probes) and analysed by flow cytometry (FACScalibur, Becton Dickinson).
Immunofluorescence Cells were seeded onto poly-L-lysine (Sigma)-treated coverslips, stained with an anti-cytochrome c antibody (Becton Dickinson) and mounted as described (Klee and PimentelMuin˜os, 2005) . For confocal studies, we used the 488-and/ or 543-nm bands of a Zeiss LSM-510 microscope. In vivo confocal microscopy was performed as described (Klee and Pimentel-Muin˜os, 2005) . Scale bars represent 10 mm unless otherwise indicated (electron microscopy).
Electron microscopy
Transfected cells were fixed with 2.5% glutaraldehyde followed by 1% osmium tetroxide containing 0.8% potassium ferricyanide. After dehydration, ultrathin sections were stained with 2% uranyl acetate and lead citrate and observed under a JEM-1010 electron microscope (Jeol, Tokyo, Japan).
Coimmunoprecipitation Cells were lysed as described above (western blotting). After taking a sample as total lysate, post-nuclei supernatants were precleared with 15 ml of packed Sepharose beads (GE Healthcare, Little Chalfont, UK). Immunoprecipitations were performed for 1 h (293T) or 3 h (HeLa) using 10 ml of agarose beads coupled to an anti-HA mAb (Roche), or for 3 h with 3 mg of an anti-ANT antibody (Santa Cruz) followed by a 1 h incubation with 15 ml of packed Sepharose beads coupled to protein G (GE Healthcare). Beads were washed five times with lysis buffer containing 0.9 M NaCl (293T) or lysis buffer (HeLa) and resuspended in sample buffer. Equal volumes were then subjected to anti-AU1 immunoblotting.
siRNA studies HeLa cells were transfected with predesigned pools of RNA duplexes (On-TargetPlus, Dharmacon, Lafayette, CO, USA) using DharmaFECT1 (Dharmacon), according to product instructions. Individual siRNAs targeting PiC were also from Dharmacon and their sequences were: PiC1: gggcauauuuaacg gauucuu; PiC2: gccaacacuuugagggauguu. For semiquantita tive PCR, cDNA was generated using the SuperscriptII kit (Invitrogen). PCR conditions were: 951C, 1 0 ; 661C, 1 0 ; 721C, 1 0 ; for 22 (PiC), 24 (MTCH2), 26 (ANT1) or 21 (Actin) cycles. Oligonucleotides were: PiC: fw, tgcttctctggtcctcaagagact, rev, cagattcagtccacatttgctttg; ANT1: fw, gcttggagcttcctaaaggacttc, rev, agggattctcaccacacaatcaat; MTCH2: fw, ggtgaggagttagga cctggaaat, rev, cgaaaaatcctagaatgccctctt; Actin: fw, agatcaagat cattgctcctcctg, rev, cttgttttctgcgcaagttaggtt.
Abbreviations PARP, poly(ADP-ribose) polymerase; PI, propidium iodide; STS, staurosporine.
